United States Pharmaceuticals

LogicBio Therapeutics Inc (LOGC)

Track

Ticker: LOGC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 16 Apr 2021
Value US$2,761,336.87 | Price 93.09 | Shares 15,475 (+33.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-04-19 2021-04-16 S Sale
Chereau Frederic

President and Chief Executive

Executive Director
15,475 +33.7%
93.09
US$2,761,337 		15,475 +33.7% 93.09 US$2,761,337
2020-10-05 2020-10-01 B Purchase
Chimovits Erez
Non-Executive Director Large shareholder
81,861 -34.3%
256.75
US$4,585,213 		81,861 -34.3% 256.75 US$4,585,213
2020-10-05 2020-10-01 B Purchase
Chimovits Erez
Non-Executive Director Large shareholder
14,464 +47.2%
33.95
US$374,856 		14,464 +47.2% 33.95 US$374,856
2020-10-05 2020-10-01 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
296,296 +inf%
6.00
US$1,777,776 		296,296 +inf% 6.00 US$1,777,776
2020-10-05 2020-10-01 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
639,212 +18.3%
6.00
US$3,835,272 		639,212 +18.3% 6.00 US$3,835,272
2020-10-05 2020-10-01 B Purchase
Chimovits Erez
Non-Executive Director Large shareholder
545,974 +18.3%
6.00
US$3,275,844 		545,974 +18.3% 6.00 US$3,275,844
2020-10-05 2020-10-01 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
545,974 +18.3%
6.00
US$3,275,844 		545,974 +18.3% 6.00 US$3,275,844
2020-10-05 2020-09-28 S Sale
3.2
Arix Bioscience plc
Large shareholder
273,584 -10.3%
7.54
US$2,061,866 		273,584 -10.3% 7.54 US$2,061,866
2020-10-05 2020-09-25 S Sale
3.2
Arix Bioscience plc
Large shareholder
174,219 -6.2%
7.08
US$1,232,948 		174,219 -6.2% 7.08 US$1,232,948
2020-10-05 2020-09-24 S Sale
3.2
Arix Bioscience plc
Large shareholder
38,514 -1.3%
7.63
US$293,823 		38,514 -1.3% 7.63 US$293,823
2020-10-05 2020-08-13 S Sale
3.2
Arix Bioscience plc
Large shareholder
159 -0.0%
8.75
US$1,391 		159 -0.0% 8.75 US$1,391
2020-10-05 2020-08-12 S Sale
3.2
Arix Bioscience plc
Large shareholder
1,335 -0.0%
8.79
US$11,735 		1,335 -0.0% 8.79 US$11,735
2020-10-05 2020-07-29 S Sale
3.2
Arix Bioscience plc
Large shareholder
2,709 -0.1%
8.78
US$23,788 		2,709 -0.1% 8.78 US$23,788
2020-10-05 2020-07-22 S Sale
3.2
Arix Bioscience plc
Large shareholder
22,651 -0.8%
9.00
US$203,950 		22,651 -0.8% 9.00 US$203,950
2020-10-05 2020-07-20 S Sale
3.2
Arix Bioscience plc
Large shareholder
36,983 -1.3%
9.25
US$342,056 		36,983 -1.3% 9.25 US$342,056
2020-10-05 2020-07-17 S Sale
3.2
Arix Bioscience plc
Large shareholder
31,101 -1.0%
9.24
US$287,373 		31,101 -1.0% 9.24 US$287,373
2020-10-05 2020-07-16 S Sale
3.2
Arix Bioscience plc
Large shareholder
16,332 -0.5%
8.56
US$139,786 		16,332 -0.5% 8.56 US$139,786
2018-10-26 2018-10-23 B Purchase Arix Bioscience plc Large shareholder
700,000 +30.7%
10.00
US$7,000,000 		700,000 +30.7% 10.00 US$7,000,000
2018-10-25 2018-10-23 B Purchase Chimovits Erez Non-Executive Director
490,000 +16.3%
10.00
US$4,900,000 		490,000 +16.3% 10.00 US$4,900,000
2018-10-25 2018-10-23 B Purchase Ioannidou Sofia Non-Executive Director
420,000 +30.7%
10.00
US$4,200,000 		420,000 +30.7% 10.00 US$4,200,000
2018-10-25 2018-10-23 B Purchase Kariv Tomer Non-Executive Director
100,849 +6.0%
10.00
US$1,008,490 		100,849 +6.0% 10.00 US$1,008,490
2018-10-25 2018-10-23 B Purchase Kariv Tomer Non-Executive Director
112,000 +7.1%
10.00
US$1,120,000 		112,000 +7.1% 10.00 US$1,120,000
2018-10-25 2018-10-23 B Purchase Kariv Tomer Non-Executive Director
207,151 +15.1%
10.00
US$2,071,510 		207,151 +15.1% 10.00 US$2,071,510
2018-10-25 2018-10-23 B Purchase O'Connell Daniel P Non-Executive Director
700,000 +30.7%
10.00
US$7,000,000 		700,000 +30.7% 10.00 US$7,000,000
2018-10-25 2018-10-23 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
700,000 +12.1%
10.00
US$7,000,000 		700,000 +12.1% 10.00 US$7,000,000
2018-10-25 2018-10-23 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
490,000 +9.3%
10.00
US$4,900,000 		490,000 +9.3% 10.00 US$4,900,000
Explore more

More insider trading research around LogicBio Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America